LAS VEGAS, June 2 /PRNewswire-FirstCall/ -- Mr. Hanson has announced that the Company has entered into a Loan Agreement and Option to Purchase with AngioScan BioTech, Inc. The agreement provides that Premier Platform Holding Company, Inc. will provide a loan of $50,000 to AngioScan BioTech Inc. and later will provide an additional $1,100,000 in exchange for 48% of the stock of AngioScan BioTech, Inc. The initial $50,000 has now been raised, and is being held in escrow.
AngioScan BioTech, Inc. is a corporation that provides high definition infrared imaging in the medical field, primarily for the detection of breast cancer.
About Premier Platform Holding Company, Inc.
Premier Platform Holding Company, Inc. is a publicly held corporation. It has not had any operations or business for the past two years.
Statements about the company’s future expectations including future revenues and earnings, and all other statements in this new release other than historical facts are “forward-looking statements.” Since these statements involve risks and uncertainties and are subject to change at any time, the company’s actual results may differ materially from the company’s plans if its assumptions prove to be incorrect, or, for a variety of other reasons. Premier Platform Holding Company Inc. is not a reporting company registered under the Securities Act of 1934. Shares of its stock trade under the symbol “PPFM.”
Premier Platform Holding Company, Inc.
CONTACT: Premier Platform Holding Company, Inc., +1-702-248-9787
